国泰海通证券股份有限公司(以下简称"国泰海通"或"保荐机构")作为无锡 日联科技股份有限公司(以下简称"日联科技"或"公司")首次公开发行股票并上 市持续督导保荐机构,根据《证券发行上市保荐业务管理办法》《上市公司监管 指引第8号 -- 上市公司资金往来、对外担保的监管要求》《上海证券交易所上市 公司自律监管指引第11号 -- 持续督导》《上海证券交易所科创板股票上市规则》 《上海证券交易所科创板上市公司自律监管指引第1号——规范运作》等有关规 定,对公司为全资子公司提供担保事项进行了核查,具体情况如下: 一、担保情况概述 国泰海通证券股份有限公司 关于无锡日联科技股份有限公司 为全资子公司提供担保的核查意见 | 成立日期 | 2002 年 12 月27 日 | | --- | --- | | 注册资本 | 15,000.00 万元 | | 法定代表人 | 练红梅 | | 注册地址 | 深圳市光明区凤凰街道塘家社区光明高新产业园观光路以南、邦凯 | (一)深圳市日联科技有限公司 l | | 路以西邦凯科技工业园(一期)2#厂房Ａ区一层 102 | | | --- | --- | --- | | 与公司关系 | ...

Financial Performance - The company achieved operating revenue of CNY 739,495,926.25 in 2024, representing a year-on-year growth of 25.89%[20]. - The net profit attributable to shareholders reached CNY 143,304,426.86, an increase of 25.44% compared to the previous year[20]. - The net cash flow from operating activities was CNY 31,419,904.92, showing a significant increase of 280.40% year-on-year[20]. - The basic earnings per share for 2024 were CNY 1.25, reflecting a growth of 20.19% from the previous year[19]. - The weighted average return on equity was 4.44%, a slight decrease of 0.08 percentage points compared to 2023[19]. - The company’s net assets attributable to shareholders were CNY 3,230,328,667.49 at the end of 2024, a decrease of 0.89% from the end of 2023[18]. - The total assets increased by 2.05% year-on-year, reaching CNY 3,639,123,938.43 at the end of 2024[18]. - The total cash dividends for the year, including interim distributions, amount to 90,349,342.40 CNY, while the total amount for share buybacks is 103,201,767.63 CNY, making the combined total 193,551,110.03 CNY, which represents 135.06% of the net profit attributable to shareholders[4]. Research and Development - The company invested 8,151.73 million RMB in R&D during the reporting period, accounting for 11.02% of operating revenue[34]. - The company has developed advanced core technologies in industrial X-ray, including X-ray source and intelligent detection equipment, maintaining industry-leading technical levels[86]. - The company has established multiple R&D departments focused on X-ray intelligent detection equipment, with ongoing projects tailored to specific customer needs in various application fields[50]. - The company has successfully developed and mass-produced a series of micro-focus X-ray sources, enhancing its core competitiveness through independent control over product design and key materials[47]. - The company is committed to increasing R&D investment to develop micro to nano-level X-ray sources and various industrial application imaging software[167]. Market Expansion and Strategy - The company is actively expanding its global presence with subsidiaries or factories in Singapore, Malaysia, Hungary, and the USA[109]. - The company plans to enhance its market share in self-produced X-ray sources and expand its overseas sales channels and service networks[166]. - The company aims to achieve a breakthrough in key components such as magnetrons and photon detectors, and develop a general software algorithm platform for the detection field[42]. - The company plans to adopt a "horizontal expansion and vertical deepening" strategy through investments and acquisitions of advanced detection equipment or core component manufacturers, aiming to cover more product categories and capture more niche markets[171]. - The company is exploring potential mergers and acquisitions to strengthen its competitive position and enhance operational capabilities[180]. Corporate Governance and Management - The company has established a robust corporate governance structure in compliance with relevant laws and regulations, ensuring effective operation and coordination among the board of directors, supervisory board, and shareholders[174]. - The company has successfully passed all resolutions in its shareholder meetings, indicating strong governance and stakeholder engagement[177]. - The total remuneration for all directors, supervisors, and senior management at the end of the reporting period amounted to 702.28 million[189]. - The company held a total of 8 board meetings during the year, all conducted in person[193]. - The company plans to implement a "quality improvement and efficiency enhancement" action plan for 2024[192]. Risks and Challenges - The company faces risks related to potential leakage of core technology secrets and the possibility of R&D projects failing to achieve commercialization[111]. - The company is exposed to risks from international trade tensions, which could affect its supply chain and production operations if export restrictions are imposed[127]. - The company faces competition from established foreign manufacturers in the X-ray source market, which may impact its market share and customer recognition[126]. - The company must continue to invest in technology development to keep pace with rapid advancements in the industry and avoid obsolescence[126]. - Changes in tax incentive policies could increase the company's tax burden, impacting profitability if it no longer qualifies for preferential tax rates[119]. Employee and Talent Management - The total number of employees reached 972 by the end of the reporting period, with an increase of 93 employees compared to the end of 2023, and R&D personnel accounted for 25.82%[38]. - The company has established a comprehensive employee promotion and compensation management system, enhancing human resource management efficiency[38]. - Total compensation for R&D personnel rose to 5,281.77 million, up from 4,322.21 million, with average compensation increasing to 21.04 million from 19.38 million[98]. - The company plans to continue attracting and developing talent, optimizing its talent structure and enhancing employee training programs to improve overall business capabilities[170]. Product Development and Innovation - The company has developed a series of X-ray intelligent detection equipment with high detection accuracy and efficiency, particularly in the fields of integrated circuits and new energy batteries[44]. - The company is leading in the industrial X-ray AI detection field, having developed proprietary software for image processing and defect recognition, significantly improving detection coverage and accuracy[52]. - The company has successfully implemented small-batch trials for open-tube X-ray sources and integrated high-power small-focus X-ray sources, accelerating the process of import substitution[71]. - The company has developed a series of online 3D/CT intelligent detection equipment and has achieved mass production of closed hot cathode micro-focus X-ray sources[99]. - The company is focusing on R&D for X-ray technology, aiming to replace imported core components and improve detection precision and efficiency through AI algorithms and 3D/CT scanning technology[165].

Financial Performance - The company's operating revenue for Q1 2025 was CNY 199,506,647.54, representing a 33.19% increase compared to CNY 149,792,186.73 in the same period last year[3] - Net profit attributable to shareholders was CNY 35,328,431.69, a 4.45% increase from CNY 33,823,111.62 year-over-year[3] - The company reported non-recurring gains of CNY 15,459,662.82, primarily from government subsidies and financial product income[6] - Total operating revenue for Q1 2025 reached ¥199.51 million, a 33.2% increase from ¥149.79 million in Q1 2024[18] - Net profit for Q1 2025 was ¥34.90 million, compared to ¥33.82 million in Q1 2024, reflecting a growth of 3.2%[19] - Operating profit for Q1 2025 was ¥39.37 million, an increase of 13.3% from ¥34.56 million in Q1 2024[19] Cash Flow - The net cash flow from operating activities improved significantly to CNY 4,513,798.07, compared to a negative cash flow of CNY -9,051,858.36 in the previous year[3] - The company experienced a 149.87% increase in net cash flow from operating activities, attributed to expanded sales scale and increased cash receipts from sales[7] - Cash flow from operating activities for Q1 2025 was ¥4.51 million, a significant improvement from a negative cash flow of ¥9.05 million in Q1 2024[20] - Cash inflow from investment activities in Q1 2025 totaled ¥837.01 million, compared to ¥978.33 million in Q1 2024[20] - The net increase in cash and cash equivalents for the period was $34,011,295.24, contrasting with a decrease of $66,313,816.96 in the previous period[21] Assets and Liabilities - Total assets at the end of the reporting period were CNY 3,683,297,133.67, a 1.21% increase from CNY 3,639,123,938.43 at the end of the previous year[4] - The company's cash and cash equivalents increased to RMB 146,144,353.00 from RMB 107,344,277.65, reflecting a growth of approximately 36.2%[14] - Accounts receivable rose to RMB 325,254,715.75, up from RMB 295,779,196.34, indicating an increase of about 9.9%[14] - Inventory levels increased to RMB 266,575,184.35 from RMB 255,025,601.76, representing a growth of approximately 4.5%[14] - The total current liabilities slightly increased to RMB 386,378,029.21 from RMB 384,119,322.04, showing a marginal rise of about 0.6%[15] - The total liabilities as of the end of the reporting period were ¥412.29 billion, slightly up from ¥408.80 billion in the previous period[16] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 7,944[8] - The largest shareholder, Wuxi Rilian Industrial Co., Ltd., holds 27.41% of the shares, totaling 31,384,380 shares[9] - The company has not reported any significant changes in shareholder structure or major strategic shifts during the reporting period[12] Research and Development - Research and development expenses totaled CNY 24,034,118.77, which is 12.05% of operating revenue, down from 13.63% in the previous year[3] - Research and development expenses for Q1 2025 were ¥24.03 million, up from ¥20.42 million in Q1 2024, indicating a focus on innovation[18] Equity and Return Metrics - The weighted average return on equity increased to 1.07%, up by 0.03 percentage points from 1.04% in the same period last year[3] - The total equity attributable to shareholders increased to ¥3.27 billion from ¥3.23 billion, reflecting a positive trend in shareholder value[16] Future Outlook - The company is set to implement new accounting standards starting in 2025, which may affect future financial reporting[21]

无锡日联科技股份有限公司 2024年度独立董事述职报告 本人董伟作为无锡日联科技股份有限公司（以下简称"公司"）的独立董事， 在 2024 年度任期内（2024 年 1 月 1 日至 2024 年 5 月 27 日）严格按照《公司法》 《上市公司独立董事管理办法》等相关法律法规和规章制度及《公司章程》《独 立董事工作制度》等公司制度的规定和要求，在履职期间忠实勤勉、恪尽职守， 认真出席董事会及各专门委员会会议，积极履行职责，独立自主决策，切实维护 公司和全体股东尤其是中小股东的合法权益。现将 2024 年度工作情况报告如下： 一、独立董事的基本情况 （一）个人工作履历、专业背景及兼职情况 董伟女士，1969 年出生，中国国籍，无境外永久居留权，中共江苏省委党 校硕士研究生学历。1998 年 6 月至 2011 年 2 月，历任中国农业银行无锡各支行 客户经理、支行副行长、行长、总经理等职务；2011 年 2 月至 2024 年 9 月，历 任华夏银行无锡锡沪支行、江阴支行、城中支行行长、分行营销总监等职务，现 已退休。2021 年 12 月至 2024 年 5 月，担任日联科技独立董事。 （二）独立性说明 作 ...

无锡日联科技股份有限公司 2024年度独立董事述职报告 2024 年度任期内，作为无锡日联科技股份有限公司（以下简称"公司"或 "日联科技"）的独立董事，我按照《中华人民共和国公司法》《中华人民共和 国证券法》《上海证券交易所科创板股票上市规则》等法律法规及《无锡日联科 技股份有限公司章程》（以下简称"《公司章程》"）《无锡日联科技股份有限 公司独立董事工作制度》（以下简称"《独立董事工作制度》"）等规定，本着 对全体股东负责的态度，忠实、勤勉地履行职责，积极发挥独立董事的作用，维 护公司和全体股东尤其是中小股东的合法权益。现将 2024 年度任期内履职情况 报告如下： 一、独立董事的基本情况 （一）个人工作履历、专业背景及兼职情况 杜志军先生，1980年出生，中国国籍，无境外永久居留权，华东政法大学硕 士研究生学历。2002年7月至2004年4月，任无锡市南长区人民法院书记员；2004 年4月至2005年7月，任无锡市中级人民法院研究室书记员；2005年7月至2014年9 月任锡市中级人民法院民二知产庭四级法官；2014年9月至2017年2月，任江苏辰 庚律师事务所律师；2017年2月至2018年6月，任北 ...

日联科技集团股份有限公司 章 程 二〇二五年四月 | | | | | | 日联科技集团股份有限公司 章 程 第一章 总 则 第一条 为维护公司、股东、职工和债权人的合法权益，规范公司的组织和 行为，根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人民 共和国证券法》（以下简称"《证券法》"）、《上市公司章程指引》等法律法规 及规范性文件的有关规定，制订本章程。 第二条 公司系依照《公司法》和其他有关规定成立的股份有限公司（以下 简称"公司"）。 公司由无锡日联科技有限公司依法以整体变更方式设立；在无锡市行政审 批局注册登记，取得营业执照，统一社会信用代码：91320200692568341T。 第三条 公司于 2023 年 2 月 21 日经中华人民共和国证券监督管理委员会（以 下简称为"中国证监会"）注册，首次公开发行人民币普通股 1,985.1367 万股，股 票于 2023 年 3 月 31 日在上海证券交易所科创板上市交易。 第四条 公司中文名称：日联科技集团股份有限公司 公司英文名称：Unicomp Technology Group Co., Ltd. 第五条 公司住所：无锡市新吴区漓 ...

无锡日联科技股份有限公司 2024年度独立董事述职报告 2024 年度，作为无锡日联科技股份有限公司（以下简称"公司"或"日联 科技"）的独立董事，我按照《中华人民共和国公司法》《中华人民共和国证券 法》《上海证券交易所科创板股票上市规则》等法律法规及《无锡日联科技股份 有限公司章程》（以下简称"《公司章程》"）《无锡日联科技股份有限公司独 立董事工作制度》（以下简称"《独立董事工作制度》"）等规定，本着对全体 股东负责的态度，忠实、勤勉地履行职责，积极发挥独立董事的作用，维护公司 和全体股东尤其是中小股东的合法权益。现将 2024 年度履职情况报告如下： 一、独立董事的基本情况 （一）个人工作履历、专业背景及兼职情况 张桂珍女士，1964 年出生，中国国籍，无境外永久居留权，江苏广播电视 大学大专学历，注册会计师。1981 年 11 月至 1995 年 12 月，担任无锡第一棉纺 织厂科员；1996 年 1 月至 2007 年 10 月，担任无锡大公税务师事务所项目经理； 2007 年 11 月至 2008 年 12 月，担任无锡公勤会计师事务所项目经理。2009 年 1 月至今，担任江苏中证会计师事务所有 ...

无锡日联科技股份有限公司 2024年度独立董事述职报告 2024 年度，作为无锡日联科技股份有限公司（以下简称"公司"或"日联 科技"）的独立董事，我按照《中华人民共和国公司法》《中华人民共和国证券 法》《上海证券交易所科创板股票上市规则》等法律法规及《无锡日联科技股份 有限公司章程》（以下简称"《公司章程》"）《无锡日联科技股份有限公司独 立董事工作制度》（以下简称"《独立董事工作制度》"）等规定，本着对全体 股东负责的态度，忠实、勤勉地履行职责，积极发挥独立董事的作用，维护公司 和全体股东尤其是中小股东的合法权益。现将 2024 年度履职情况报告如下： 吴懿平先生，1957 年出生，中国国籍，无境外永久居留权，华中科技大学 工学博士。1982 年 2 月至 2023 年 1 月历任华中科技大学助教、讲师、副教授、 教授、博士生导师，现已退休；1997 年 7 月至 1999 年 5 月、2002 年 6 月至 2003 年 6 月担任香港城市大学电子工程学科访问学者、研究员；2003 年 6 月至 2006 年 6 月担任上海交通大学机器人研究所特聘教授。2011 年 5 月至今担任广东华 南半导体光电研 ...

根据证监会《上市公司独立董事管理办法》《上海证券交易所科创板股票上 市规则》《上海证券交易所上市公司自律监管指引第 1 号－－规范运作》等要求， 无锡日联科技股份有限公司（以下简称"公司"）董事会就公司在任独立董事吴 懿平、张桂珍、杜志军的独立性情况进行评估并出具如下专项意见： 经核查独立董事吴懿平、张桂珍、杜志军的任职经历以及签署的相关自查文 件，上述人员未在公司担任除独立董事以外的任何职务，也未在公司主要股东公 司担任任何职务，与公司以及主要股东之间不存在利害关系或其他可能妨碍其进 行独立客观判断的关系，因此，公司独立董事符合《上市公司独立董事管理办法》 《上海证券交易所科创板上市公司自律监管指引第 1 号－－规范运作》中对独立 董事独立性的相关要求。 无锡日联科技股份有限公司董事会关于独立董事独立性情 况的专项意见 2025 年 4 月 25 日 无锡日联科技股份有限公司董事会 ...

Core Insights - The company is a leading player in China's industrial X-ray source and detection equipment sector, breaking the overseas monopoly in integrated circuits, electronic manufacturing, new energy batteries, and material testing, thus facilitating domestic substitution [1][2]. Business Overview - In 2024, the company reported a revenue of 740 million yuan and a net profit attributable to shareholders of 140 million yuan, with a non-recurring net profit of 95 million yuan. The revenue structure for the first half of 2024 shows that X-ray detection equipment, spare parts, and others accounted for 87% and 12% of total revenue, with gross margins of 41% and 74% respectively [2][3]. - The X-ray detection equipment business includes revenue contributions from integrated circuit electronic manufacturing (41%), cast products (27%), and new energy battery automatic detection systems (17%), with corresponding gross margins of 48%, 37%, and 33% [2][3]. Market Position and Competitive Advantage - The company has achieved a breakthrough in micro-focus X-ray sources, establishing a competitive landscape with Japanese and American firms, creating a tripartite competition in the global market [2]. - The company is positioned to benefit from high-end product breakthroughs and the drive for import substitution, indicating significant growth potential [2][3]. Financial Performance and Projections - The company’s revenue from high-end spare parts has reached 12% of total revenue in the first half of 2024, with a high gross margin of 74%. The revenue from X-ray detection equipment for integrated circuit manufacturing grew by 32% in the first half of 2024, indicating strong demand and growth potential in this sector [3]. - The company has a robust cash flow with approximately 2.4 billion yuan in cash equivalents as of the third quarter of 2024, providing a solid foundation for future development [3]. Profit Forecast and Valuation - The projected net profits for the company from 2024 to 2026 are 140 million yuan, 220 million yuan, and 300 million yuan, representing year-on-year growth rates of 24%, 55%, and 38% respectively. The corresponding price-to-earnings ratios are expected to be 50, 32, and 24 times [4]. - The anticipated tariff policies are expected to accelerate the domestic production of X-ray sources and detection equipment, potentially increasing the company's market share. A target price of 85.98 yuan is set for 2025, with a recommended "buy" rating [4].